Suboptimal immunization coverage among Canadian rheumatology patients in routine clinical care

From the Department of Medicine, McGill University, Montreal; Division of Rheumatology, McGill University Health Center, Montreal; Infectious Diseases and Immunity in Global Health Program, Research Institute of the McGill University Health Center, Montreal; Division of Rheumatology and Lady Davis Institute for Medical Research, Jewish General hospital, Montreal, Canada; Internal Medicine, Rheumatology and Immunology, Centro de Educacion Medica e Investigaciones Clinicas Norberto Quirno, Buenos Aires, Argentina. This research was in part supported by the Canadian Rheumatology Association and a 2016 Canadian Institute for Outcomes in Rheumatology cAre (CIORA) grant on “Strategies to enhance Influenza/Pneumococcal vaccination coverage among rheumatoid arthritis patients”. Address correspondence to Dr. M. Hudson, Jewish General Hospital and Lady David Research Institute, 3755 Côte Ste-Catherine Road, Room A725, Montreal, QC H3T 1E2, Canada. E-mail: marie.hudson@mcgill.ca

From the Department of Medicine, McGill University, Montreal; Division of Rheumatology, McGill University Health Center, Montreal; Infectious Diseases and Immunity in Global Health Program, Research Institute of the McGill University Health Center, Montreal; Division of Rheumatology and Lady Davis Institute for Medical Research, Jewish General hospital, Montreal, Canada; Internal Medicine, Rheumatology and Immunology, Centro de Educacion Medica e Investigaciones Clinicas Norberto Quirno, Buenos Aires, Argentina. This research was in part supported by the Canadian Rheumatology Association and a 2016 Canadian Institute for Outcomes in Rheumatology cAre (CIORA) grant on “Strategies to enhance Influenza/Pneumococcal vaccination coverage among rheumatoid arthritis patients”. Address correspondence to Dr. M. Hudson, Jewish General Hospital and Lady David Research Institute, 3755 Côte Ste-Catherine Road, Room A725, Montreal, QC H3T 1E2, Canada. E-mail: marie.hudson@mcgill.ca

From the Department of Medicine, McGill University, Montreal; Division of Rheumatology, McGill University Health Center, Montreal; Infectious Diseases and Immunity in Global Health Program, Research Institute of the McGill University Health Center, Montreal; Division of Rheumatology and Lady Davis Institute for Medical Research, Jewish General hospital, Montreal, Canada; Internal Medicine, Rheumatology and Immunology, Centro de Educacion Medica e Investigaciones Clinicas Norberto Quirno, Buenos Aires, Argentina. This research was in part supported by the Canadian Rheumatology Association and a 2016 Canadian Institute for Outcomes in Rheumatology cAre (CIORA) grant on “Strategies to enhance Influenza/Pneumococcal vaccination coverage among rheumatoid arthritis patients”. Address correspondence to Dr. M. Hudson, Jewish General Hospital and Lady David Research Institute, 3755 Côte Ste-Catherine Road, Room A725, Montreal, QC H3T 1E2, Canada. E-mail: marie.hudson@mcgill.ca

From the Department of Medicine, McGill University, Montreal; Division of Rheumatology, McGill University Health Center, Montreal; Infectious Diseases and Immunity in Global Health Program, Research Institute of the McGill University Health Center, Montreal; Division of Rheumatology and Lady Davis Institute for Medical Research, Jewish General hospital, Montreal, Canada; Internal Medicine, Rheumatology and Immunology, Centro de Educacion Medica e Investigaciones Clinicas Norberto Quirno, Buenos Aires, Argentina. This research was in part supported by the Canadian Rheumatology Association and a 2016 Canadian Institute for Outcomes in Rheumatology cAre (CIORA) grant on “Strategies to enhance Influenza/Pneumococcal vaccination coverage among rheumatoid arthritis patients”. Address correspondence to Dr. M. Hudson, Jewish General Hospital and Lady David Research Institute, 3755 Côte Ste-Catherine Road, Room A725, Montreal, QC H3T 1E2, Canada. E-mail: marie.hudson@mcgill.ca

From the Department of Medicine, McGill University, Montreal; Division of Rheumatology, McGill University Health Center, Montreal; Infectious Diseases and Immunity in Global Health Program, Research Institute of the McGill University Health Center, Montreal; Division of Rheumatology and Lady Davis Institute for Medical Research, Jewish General hospital, Montreal, Canada; Internal Medicine, Rheumatology and Immunology, Centro de Educacion Medica e Investigaciones Clinicas Norberto Quirno, Buenos Aires, Argentina. This research was in part supported by the Canadian Rheumatology Association and a 2016 Canadian Institute for Outcomes in Rheumatology cAre (CIORA) grant on “Strategies to enhance Influenza/Pneumococcal vaccination coverage among rheumatoid arthritis patients”. Address correspondence to Dr. M. Hudson, Jewish General Hospital and Lady David Research Institute, 3755 Côte Ste-Catherine Road, Room A725, Montreal, QC H3T 1E2, Canada. E-mail: marie.hudson@mcgill.ca

From the Department of Medicine, McGill University, Montreal; Division of Rheumatology, McGill University Health Center, Montreal; Infectious Diseases and Immunity in Global Health Program, Research Institute of the McGill University Health Center, Montreal; Division of Rheumatology and Lady Davis Institute for Medical Research, Jewish General hospital, Montreal, Canada; Internal Medicine, Rheumatology and Immunology, Centro de Educacion Medica e Investigaciones Clinicas Norberto Quirno, Buenos Aires, Argentina. This research was in part supported by the Canadian Rheumatology Association and a 2016 Canadian Institute for Outcomes in Rheumatology cAre (CIORA) grant on “Strategies to enhance Influenza/Pneumococcal vaccination coverage among rheumatoid arthritis patients”. Address correspondence to Dr. M. Hudson, Jewish General Hospital and Lady David Research Institute, 3755 Côte Ste-Catherine Road, Room A725, Montreal, QC H3T 1E2, Canada. E-mail: marie.hudson@mcgill.ca

From the Department of Medicine, McGill University, Montreal; Division of Rheumatology, McGill University Health Center, Montreal; Infectious Diseases and Immunity in Global Health Program, Research Institute of the McGill University Health Center, Montreal; Division of Rheumatology and Lady Davis Institute for Medical Research, Jewish General hospital, Montreal, Canada; Internal Medicine, Rheumatology and Immunology, Centro de Educacion Medica e Investigaciones Clinicas Norberto Quirno, Buenos Aires, Argentina. This research was in part supported by the Canadian Rheumatology Association and a 2016 Canadian Institute for Outcomes in Rheumatology cAre (CIORA) grant on “Strategies to enhance Influenza/Pneumococcal vaccination coverage among rheumatoid arthritis patients”. Address correspondence to Dr. M. Hudson, Jewish General Hospital and Lady David Research Institute, 3755 Côte Ste-Catherine Road, Room A725, Montreal, QC H3T 1E2, Canada. E-mail: marie.hudson@mcgill.ca